| Dr Thomas R Moore, MD | |
|
9350 Campus Point Dr, 2c, La Jolla, CA 92037 | |
| (858) 657-8526 | |
| (858) 657-8666 |
| Full Name | Dr Thomas R Moore |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 9350 Campus Point Dr, La Jolla, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184682379 | NPI | - | NPPES |
| ZZZP3721Z | Medicaid | CA | |
| G49930 | Other | CA | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | G49930 (California) | Secondary |
| 207V00000X | Obstetrics & Gynecology | G49930 (California) | Primary |
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326141862 PECOS PAC ID: 3577476761 Enrollment ID: O20031209001111 |
News Archive
The liver is unique among mammalian organs in its ability to regenerate after significant tissue damage or even partial surgical removal. Laurie DeLeve and her colleagues at the University of Southern California in Los Angeles wanted to better understand which cells are specifically responsible for driving liver regeneration.
Drugs approved for treatment of specific maladies sometimes show unexpected benefits. Researchers at the 95th annual meeting of the American Association for Cancer Research demonstrated highlighted how some drugs may one day offer previously unforeseen benefits for patients.
Ipsen, a global biopharmaceutical group, and Invida Group, the leading healthcare commercialization solutions partner in the Asia Pacific region, announced today an agreement for the exclusive distribution and promotion by Invida of Ipsen's drugs Diphereline® 3.75mg & 11.25mg, Somatuline® Autogel® and Increlex® in selected countries in South-East Asia.
The collaboration will address a gap in analytical tests and standards applied for drugs based on glycoproteins, which now form the majority of approved biopharmaceutical drugs. Current analytical methods for characterizing glycans are time-consuming and difficult to deploy in commercial environments. They are also limited in their ability to detect and analyze minor glycan species.
The United States Food and Drug Administration (FDA) announced it is revising safety information on the labels of some statins (cholesterol lowering drugs).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas R Moore, MD 200 W Arbor Dr, Department Of Reproductive Medicine, San Diego, CA 92103-9000 Ph: (619) 543-7900 | Dr Thomas R Moore, MD 9350 Campus Point Dr, 2c, La Jolla, CA 92037 Ph: (858) 657-8526 |
News Archive
The liver is unique among mammalian organs in its ability to regenerate after significant tissue damage or even partial surgical removal. Laurie DeLeve and her colleagues at the University of Southern California in Los Angeles wanted to better understand which cells are specifically responsible for driving liver regeneration.
Drugs approved for treatment of specific maladies sometimes show unexpected benefits. Researchers at the 95th annual meeting of the American Association for Cancer Research demonstrated highlighted how some drugs may one day offer previously unforeseen benefits for patients.
Ipsen, a global biopharmaceutical group, and Invida Group, the leading healthcare commercialization solutions partner in the Asia Pacific region, announced today an agreement for the exclusive distribution and promotion by Invida of Ipsen's drugs Diphereline® 3.75mg & 11.25mg, Somatuline® Autogel® and Increlex® in selected countries in South-East Asia.
The collaboration will address a gap in analytical tests and standards applied for drugs based on glycoproteins, which now form the majority of approved biopharmaceutical drugs. Current analytical methods for characterizing glycans are time-consuming and difficult to deploy in commercial environments. They are also limited in their ability to detect and analyze minor glycan species.
The United States Food and Drug Administration (FDA) announced it is revising safety information on the labels of some statins (cholesterol lowering drugs).
› Verified 9 days ago
Renee Marleen Nelson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9850 Genesee Ave, #60, La Jolla, CA 92037 Phone: 858-453-0753 Fax: 858-642-4270 | |
Mariann Alperin, M.D., M.S. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9350 Campus Point Drive, Ste 2a, Mc 0974, Ucsd Women's Pelvic Medicine, La Jolla, CA 92037 Phone: 858-657-8435 | |
Dr. Alice S Park, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 9300 Campus Point Dr, Mail Code 0633, La Jolla, CA 92037 Phone: 888-309-8273 | |
Dr. Mel M. Kurtulus, M.D. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 9850 Genesee Ave Ste 640, La Jolla, CA 92037 Phone: 858-677-0777 Fax: 858-677-0666 | |
Benito Villanueva, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 9850 Genesee Ave, Suite 410, La Jolla, CA 92037 Phone: 858-550-4954 Fax: 858-550-4946 | |
Dr. Seth Daniel Bulow, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 9834 Genesee Ave, Suite 400, La Jolla, CA 92037 Phone: 858-622-9076 | |
Dr. John J. Willems, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-764-9080 |